Two cases of primary unresectable and/or recurrent gastrointestinal stromal tumors of small intestine presenting hemoperitoneum caused by administration of imatinib mesylate

Japanese Journal of Gastroenterology

Volumn 105, Issue 11, 2008, Pages 1619-1626

  Yokoyama, Akira ^b   Dairaku, Naohiro ^b   Kusano, Masao ^b   Koshita, Shinsuke ^b   Shimada, Norihiro ^b   Yamagiwa, Tetsuya ^b   Kojima, Yasuhiro ^b   Ojima, Toshiaki ^b   Ikeya, Shinichi ^b   Nakayama, Haruo ^b   Sugai, Yoshiki ^b   Hiwatashi, Nobuo ^a   Asano, Shigeyuki ^a  

^a Iwaki Kyoritsu General Hospital   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; IMATINIB; VIMENTIN; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; CASE REPORT; EMERGENCY SURGERY; GASTROINTESTINAL STROMAL TUMOR; HEMOPERITONEUM; HUMAN; JEJUNUM TUMOR; LIVER METASTASIS; MALE; ONCOGENE C KIT; RECURRENT CANCER; ABDOMINAL SURGERY; CHEMICALLY INDUCED DISORDER; EMERGENCY; FATALITY; LIVER TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; REVIEW; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EMERGENCIES; FATAL OUTCOME; GASTROINTESTINAL STROMAL TUMORS; HEMOPERITONEUM; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PIPERAZINES; PYRIMIDINES; TREATMENT OUTCOME;

EID: 58149375926     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Demetri GD, Benjamin R, Blanke CD, et al : NCCN Task Force report : management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guideline. J Natl Compr Canc Netw 5 (Suppl 2) ; S1-S29 : 2007 (Pubitemid 47067464)
2. Demetri GD, von Mehren M, Blanke CD, et al : Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 ; 472-480 : 2002
3. Yeh CN, Chen TW, Liu FY, et al : Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment. Langenbecks Arch Surg 391 ; 615-621 : 2006
4. Bonvalot S, Eldweny H, Pechoux CL, et al : impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era. Ann Surg Oncol 13 ; 1596-1603 : 2006 (Pubitemid 44951467)